GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis August 1, 2022 By Bruce SF, Cho K, Noia H, Lomonosova E, Stock E, Oplt A, Blachut B, Mullen MM, Kuroki LM, Hagemann AR, McCourt CK, Thaker PH, Khabele D, Powell MA, Mutch DG, Shriver LP, Patti GJ, and Fuh KC Molecular Cancer Therapeutics, 21(8), 1348-1359, 2022 View Publication